Effects of Topical Application of Oxymetazoline on Cultured Human Nasal Mucosa: Changes of Ciliary Activity and Histopathologic Findings

Soon Kwan Hong1^,2, Chong Nahm Kim1, Sung Min Chung1, Chun Dong Kim1, Sung Wan Byun1

Copyright ⓒ 1999. Ewha Womans University School of Medicine. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Published Online: Mar 30, 1999

Abstract

Objectives

The aim of this study is to obtain the basic knowledge for safer clinical use of oxymetazoline, one of nasal decongestants, by observing changes of ciliary activity and histopa-thologic findings after topical application of oxymetazoline to the cultured human basak mucosa.

Methods

The nasal mucosa, obtained from the inferior tubinates in healthy non-smokers without any nasal symptoms or signs, was cultured and then, exposed to oxymetazoline solu-tion at different concentrations from 0.0123% to 0.25%, containing no preservatives. Ciliary activity was observed under an inverted microscope and the histopathology of the mucosa was examined by light microscopy 1,3,6,12,24 and 48 hours after exposure, respectively.

Results

Oxymetazoline impaired ciliary activity and induced mucosal injury at dose- and time-dependent patterns. Once the ciliary activity disappeared, it was not restored at least for the next 48 hours. Furthermore, these functional and morphologic changes resulted from applying oxymetazoline at the concentration of clinical use.

Conclusion

Oxymetazoline as a topical vasoconstrictor should be administered for the minimal period even at clinical dose.

Keywords: Oxymetazoline; Culture; Human nasal mucosa; Ciliary activity; Histopathology